Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors

NCT05169944 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Brain Cancer
Malignant Brain Tumor
Recurrent Brain Tumor
Progressive Malignant Brain Tumor
Brain Tumor, Pediatric
Brain Tumor Adult

Interventions

DRUG: Magrolimab

Sponsor

University of California, San Francisco

Collaborators

[object Object]